Related Experiment Video
Updated: Aug 12, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Infusion-Site MSSA as the Source of Confirmed Toxic Shock Syndrome in a 9-Year-Old on Automated Insulin Delivery
Fabio Rotondo1,2, Sofia Siena1, Carmela De Meco1
1Department of Pediatrics, IRCCS "Casa Sollievo Della Sofferenza", San Giovanni Rotondo, Italy, operapadrepio.it.
Abstract:
Staphylococcal toxic shock syndrome is a rare toxin-mediated illness. A 9-year-old girl on automated insulin delivery presented with shock, multiorgan dysfunction, rash, and gastrointestinal symptoms. An infected infusion site grew methicillin-susceptible Staphylococcus aureus. She met CDC criteria for TSS, highlighting infusion sites as sepsis foci and supporting continuation of automated insulin delivery during critical illness.
Insights
A rare Staphylococcal toxic shock syndrome (TSS) case in a girl using automated insulin delivery highlights infusion sites as infection sources. The study supports continuing this diabetes technology during critical illness.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Endocrinology
Background:
- Staphylococcal toxic shock syndrome (TSS) is a rare, toxin-mediated illness.
- Automated insulin delivery systems are crucial for managing type 1 diabetes.
- Infusion site infections can lead to severe complications.
Purpose of the Study:
- To report a case of TSS in a pediatric patient on automated insulin delivery.
- To emphasize the role of infusion sites as potential foci for sepsis.
- To support the continued use of automated insulin delivery in critically ill patients.
Main Methods:
- Case report of a 9-year-old girl.
- Clinical presentation: shock, multiorgan dysfunction, rash, gastrointestinal symptoms.
- Microbiological analysis: methicillin-susceptible Staphylococcus aureus (MSSA) from infusion site.
Main Results:
- The patient met the CDC criteria for TSS.
- The infected infusion site was identified as the source of infection.
- Successful management while maintaining automated insulin delivery.
Conclusions:
- Infusion sites for automated insulin delivery can serve as critical foci for sepsis.
- Continuation of automated insulin delivery is supported during critical illness in selected cases.
- Early recognition and management of TSS are essential.